Maurizio Speroni

PharmExtracta SpA is the Italian company dedicated for more than 30 years to the development of phytotherapeutic and probiotic (intestinal and nonintestinal) therapeutic solutions for the gastroenterological, pediatric, gynecological and metabolic areas. PharmExtracta SpA which makes its R&D department the flagship, has developed 39 patents between raw materials and finished products, which has integrated its therapeutic solutions whose efficacy and safety is validated by 168 scientific publications in journals and high impact factor and 4 international reviews. The guarantee of a clinical result represents a daily challenge that PharmExtracta SpA transforms into an opportunity.